Biomimetic nanomedicines for precise atherosclerosis theranostics
Atherosclerosis (AS) is a leading cause of the life-threatening cardiovascular disease (CVD), creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment. Biomimetic nanomedicines (bNMs) are moving closer to fulfilling this need, pushing back the frontier of nano-ba...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2023-11-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_4d3f8e8208d24c15bd8d94029b47c6f2 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Ying Tao |e author |
| 700 | 1 | 0 | |a Xinmiao Lan |e author |
| 700 | 1 | 0 | |a Yang Zhang |e author |
| 700 | 1 | 0 | |a Chenxing Fu |e author |
| 700 | 1 | 0 | |a Lu Liu |e author |
| 700 | 1 | 0 | |a Feng Cao |e author |
| 700 | 1 | 0 | |a Weisheng Guo |e author |
| 245 | 0 | 0 | |a Biomimetic nanomedicines for precise atherosclerosis theranostics |
| 260 | |b Elsevier, |c 2023-11-01T00:00:00Z. | ||
| 500 | |a 2211-3835 | ||
| 500 | |a 10.1016/j.apsb.2022.11.014 | ||
| 520 | |a Atherosclerosis (AS) is a leading cause of the life-threatening cardiovascular disease (CVD), creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment. Biomimetic nanomedicines (bNMs) are moving closer to fulfilling this need, pushing back the frontier of nano-based drug delivery systems design. This review seeks to outline how these nanomedicines (NMs) might work to diagnose and treat atherosclerosis, to trace the trajectory of their development to date and in the coming years, and to provide a foundation for further discussion about atherosclerotic theranostics. | ||
| 546 | |a EN | ||
| 690 | |a Nanotheranostics | ||
| 690 | |a Atherosclerosis | ||
| 690 | |a Biomimetic nanomedicines | ||
| 690 | |a Drug delivery | ||
| 690 | |a Passive targeting | ||
| 690 | |a Active targeting | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Acta Pharmaceutica Sinica B, Vol 13, Iss 11, Pp 4442-4460 (2023) | |
| 787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2211383522004816 | |
| 787 | 0 | |n https://doaj.org/toc/2211-3835 | |
| 856 | 4 | 1 | |u https://doaj.org/article/4d3f8e8208d24c15bd8d94029b47c6f2 |z Connect to this object online. |